| [5] |
Lee SM, An WS. Supplementary nutrients for prevention of vascular calcification in patients with chronic kidney disease[J]. Korean J Intern Med, 2019, 34(3): 459-469. DOI: 10.3904/kjim.2019.125. |
| [6] |
Hampson KJ, Gay ML, Band ME. Pediatric nephrotic syndrome: pharmacologic and nutrition management[J]. Nutr Clin Pract, 2021, 36(2): 331-343. DOI: 10.1002/ncp.10622. |
| [7] |
Polderman N, Cushing M, McFadyen K, et al. Dietary intakes of children with nephrotic syndrome[J]. Pediatr Nephrol, 2021, 36(9): 2819-2826. DOI: 10.1007/s00467-021-05055-2. |
| [8] |
Banerjee S, Basu S, Akhtar S, et al. Free vitamin D levels in steroid-sensitive nephrotic syndrome and healthy controls[J]. Pediatr Nephrol, 2020, 35(3): 447-454. DOI: 10.1007/s00467-019-04433-1. |
| [9] |
Yang SP, Ong L, Loh TP, et al. Calcium, vitamin D, and bone derangement in nephrotic syndrome[J]. J Asean Fed Endocr Soc, 2021, 36(1): 50-55. DOI: 10.15605/jafes.036.01.12. |
| [10] |
Szymczak-Pajor I, S＇liwińska A. Analysis of association between vitamin D deficiency and insulin resistance[J]. Nutrients, 2019, 11(4): 794. DOI: 10.3390/nu11040794. |
| [11] |
Lipińska-Opaka A, Tomaszewska A, Kubiak JZ, et al. Vitamin D and immunological patterns of allergic diseases in children[J]. Nutrients, 2021, 13(1): 177. DOI: 10.3390/nu13010177. |
| [12] |
Yang S, Li A, Wang J, et al. Vitamin D receptor: a novel therapeutic target for kidney diseases[J]. Curr Med Chem, 2018, 25(27): 3256-3271. DOI: 10.2174/0929867325666180214122352. |
| [13] |
Subandiyah K, Khanifa H, Kardani AK. Effect of corticosteroid and vitamin D3 as combined therapy on 25(OH) vitamin D serum level and regulatory T (Treg) cells population in children with idiopathic nephrotic syndrome[J]. Bali Med J, 2018, 7(3): 639-644. DOI: 10.15562/bmj.v7i3.769. |
| [14] |
Song Z, Xiao C, Jia X, et al. Vitamin D/VDR protects against diabetic kidney disease by restoring podocytes autophagy[J]. Diabetes Metab Syndr Obes, 2021, 14: 1681-1693. DOI: 10.2147/Dmso.S303018. |
| [15] |
Shi W, Guo L, Liu G, et al. Protective effect of calcitriol on podocytes in spontaneously hypertensive rat[J]. J Chin Med Assoc, 2018, 81(8): 691-698. DOI: 10.1016/j.jcma.2018.01.010. |
| [16] |
Campbell KN, Tumlin JA. Protecting podocytes: a key target for therapy of focal segmental glomerulosclerosis[J]. Am J Nephrol, 2018, 47(Suppl 1): 14-29. DOI: 10.1159/000481634. |
| [17] |
Zeier M, Reiser J. suPAR and chronic kidney disease-a podocyte story[J]. Pflugers Arch, 2017, 469(7-8): 1017-1020. DOI: 10.1007/s00424-017-2026-7. |
| [18] |
Li Z, Wu N, Wang J, et al. Roles of endovascular calyx related enzymes in endothelial dysfunction and diabetic vascular complications[J]. Front Pharmacol, 2020, 11: 590614. DOI: 10.3389/fphar.2020.590614. |
| [19] |
Masola V, Zaza G, Onisto M, et al. Heparanase: another renal player controlled by vitamin D[J]. J Pathol, 2016, 238(1): 7-9. DOI: 10.1002/path.4639. |
| [20] |
Li XH, Huang XP, Pan L, et al. Vitamin D deficiency may predict a poorer outcome of IgA nephropathy[J]. BMC Nephrol, 2016, 17: 164. DOI: 10.1186/s12882-016-0378-4. |
| [21] |
Deng J, Zheng X, Xie H, et al. Calcitriol in the treatment of IgA nephropathy with non-nephrotic range proteinuria: a Meta-analysis of randomized controlled trials[J]. Clin Nephrol, 2017, 87(1): 21-27. DOI: 10.5414/CN108915. |
| [22] |
Yuan D, Fang Z, Sun F, et al. Effect of vitamin D and tacrolimus combination therapy on IgA nephropathy[J]. Med Sci Monit, 2017, 23: 3170-3177. DOI: 10.12659/msm.905073. |
| [23] |
Zhao D, Zhang CJ, Yang R, et al. Effect of 1，25(OH)2D3 on the proliferation of human mesangial cells and their expression of Ki67[J]. Genet Mol Res, 2017, 16(2): gmr16029191. DOI: 10.4238/gmr16029191. |
| [24] |
Xiaowei L, Bo W, Li L, et al. Comparison of the effects of valsartan plus activated vitamin D versus valsartan alone in IgA nephropathy with moderate proteinuria[J]. Int Urol Nephrol, 2020, 52(1): 129-136. DOI: 10.1007/s11255-019-02329-5. |
| [25] |
Tamayo M, Manzanares E, Bas M, et al. Calcitriol (1，25-dihydroxyvitamin D3) increases L-type calcium current via protein kinase a signaling and modulates calcium cycling and contractility in isolated mouse ventricular myocytes[J]. Heart Rhythm, 2017, 14(3): 432-439. DOI: 10.1016/j.hrthm.2016.12.013. |
| [26] |
Lin TC, Wu JY, Kuo ML, et al. Correlation between disease activity of pediatric-onset systemic lupus erythematosus and level of vitamin D in Taiwan: a case-cohort study[J]. J Microbiol Immunol Infect, 2018, 51(1): 110-114. DOI: 10.1016/j.jmii.2015.12.005. |
| [27] |
Correa-Rodríguez M, Pocovi-Gerardino G, Callejas-Rubio JL, et al. Vitamin D levels are associated with disease activity and damage accrual in systemic lupus erythematosus patients[J]. Biol Res Nurs, 2021, 23(3): 455-463. DOI: 10.1177/1099800420983596. |
| [28] |
Pérez-Ferro M, Romero-Bueno FI, Serrano Del Castillo C, et al. A subgroup of lupus patients with nephritis, innate T cell activation and low vitamin D is identified by the enhancement of circulating MHC class Ⅰ-related chain A[J]. Clin Exp Immunol, 2019, 196(3): 336-344. DOI: 10.1111/cei.13273. |
| [29] |
Brunner HI, Bennett MR, Gulati G, et al. Urine biomarkers to predict response to lupus nephritis therapy in children and young adults[J]. J Rheumatol, 2017, 44(8): 1239-1248. DOI: 10.3899/jrheum.161128. |
| [30] |
Yu Q, Qiao Y, Liu D, et al. Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy[J]. Arthritis Res Ther, 2019, 21(1): 19. DOI: 10.1186/s13075-018-1803-9. |
| [31] |
Go DJ, Lee JY, Kang MJ, et al. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare[J]. Lupus, 2018, 27(10): 1600-1615. DOI: 10.1177/0961203318778774. |
| [32] |
Kumar YA, Vivek K, Vinod K, et al. The effect of vitamin D supplementation on bone metabolic markers in chronic kidney disease[J]. J Bone Miner Res, 2018, 33(3): 404-409. DOI: 10.1002/jbmr.3314. |
| [33] |
Lerch C, Shroff R, Wan M, et al. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease[J]. Nephrol Dial Transplant, 2018, 33(12): 2208-2217. DOI: 10.1093/ndt/gfy012. |
| [34] |
Gluba-Brzózka A, Franczyk B, Ciakowska-Rysz A, et al. Impact of vitamin D on the cardiovascular system in advanced chronic kidney disease (CKD) and dialysis patients[J]. Nutrients, 2018, 10(6):709. DOI: 10.3390/nu10060709. |
| [35] |
Dahan I, Thawho N, Farber E, et al. The iron-Klotho-VDR axis is a major determinant of proximal convoluted tubule injury in haptoglobin 2-2 genotype diabetic nephropathy patients and mice[J]. J Diabetes Res, 2018, 2018: 7163652. DOI: 10.1155/2018/7163652. |
| [36] |
Imani PD, Aujo J, Kiguli S, et al. Chronic kidney disease impacts health-related quality of life of children in Uganda, East Africa[J]. Pediatr Nephrol, 2021, 36(2): 323-331. DOI: 10.1007/s00467-020-04705-1. |
| [1] |
Gembillo G, Cernaro V, Salvo A, et al. Role of vitamin D status in diabetic patients with renal disease[J]. Medicinca (Kaunas), 2019, 55(6): 273. DOI: 10.3390/medicina55060273. |
| [2] |
Melamed ML, Chonchol M, Gutiérrez OM, et al. The role of vitamin D in CKD stages 3 to 4: report of a scientific workshop sponsored by the national kidney foundation[J]. Am J Kidney Dis, 2018, 72(6): 834-845. DOI: 10.1053/j.ajkd.2018.06.031. |
| [3] |
Baur AC, Brandsch C, Steinmetz B, et al. Differential effects of vitamin D3 vs vitamin D2 on cellular uptake, tissue distribution and activation of vitamin D in mice and cells[J]. J Steroid Biochem Mol Biol, 2020, 204: 105768. DOI: 10.1016/j.jsbmb.2020.105768. |
| [4] |
Zhang T, Ju H, Chen H, et al. Comparison of paricalcitol and calcitriol in dialysis patients with secondary hyperparathyroidism: a Meta-analysis of randomized controlled studies[J]. Ther Apher Dial, 2019, 23(1): 73-79. DOI: 10.1111/1744-9987.12760. |
| [37] |
Shroff R, Aitkenhead H, Costa N, et al. Normal 25-hydroxyvitamin D levels are associated with less proteinuria and attenuate renal failure progression in children with CKD[J]. J Am Soc Nephrol, 2016, 27(1): 314-322. DOI: 10.1681/ASN.2014090947. |
| [38] |
Paydas S, Karaer R, Kara E. Pleiotrophic effects of vitamin D in proteinuric chronic kidney disease patients[J]. Turk Neph Dial Transpl, 2018, 27(1): 76-81. DOI: 10.5262/tndt.2018.1001.06. |
| [39] |
Govender D, Damjanovic L, Gaza CA, et al. Vitamin D decreases silencer methylation to downregulate renin gene expression[J]. Gene, 2021, 786: 145623. DOI: 10.1016/j.gene.2021.145623. |
| [40] |
Zhang YL, Qiao SK, Guo XN, et al. Arsenic trioxide-induced cell apoptosis and cell cycle arrest are potentiated by 1，25-dihydroxyvitamin D3 in human leukemia K562 cells[J]. Oncol Lett, 2021, 22(1): 509. DOI: 10.3892/ol.2021.12770. |
| [41] |
Sergeev IN. Vitamin D status and vitamin D-dependent apoptosis in obesity[J]. Nutrients, 2020, 12(5): 1392. DOI: 10.3390/nu12051392. |
| [42] |
Wu CC, Liao MT, Hsiao PJ, et al. Antiproteinuria effect of calcitriol in patients with chronic kidney disease and vitamin D deficiency: a randomized controlled study[J]. J Ren Nutr, 2020, 30(3): 200-207. DOI: 10.1053/j.jrn.2019.09.001. |
| [43] |
Ahmed OM, Ali TM, Abdel Gaid MA, et al. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α，p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats[J]. PLoS One, 2019, 14(9): e0214349. DOI: 10.1371/journal.pone.0214349. |
| [44] |
Hamzawy M, Gouda S, Rashid L, et al. The cellular selection between apoptosis and autophagy: roles of vitamin D, glucose and immune response in diabetic nephropathy[J]. Endocrine, 2017, 58(1): 66-80. DOI: 10.1007/s12020-017-1402-6. |
| [45] |
Galior K, Grebe S, Singh R. Development of vitamin D toxicity from overcorrection of vitamin D deficiency: a review of case reports[J]. Nutrients, 2018, 10(8): 953. DOI: 10.3390/nu10080953. |
| [46] |
Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, et al. Vitamin D toxicity-a clinical perspective[J]. Front Endocrinol (Lausanne), 2018, 9: 550. DOI: 10.3389/fendo.2018.00550. |
| [47] |
Abdullah A, Hussain S, Rita A, et al. Vitamin D intoxication and nephrocalcinosis in a young breastfed infant[J]. Case Rep Endocrinol, 2021, 2021: 3286274. DOI: 10.1155/2021/3286274. |